For pharmaceutical and biotech innovators as well as governments and NGOs taking on the world’s foremost public health threats, Emergent CDMO has the scientific and regulatory experience, end-to-end development and manufacturing expertise, and seamless technology transfer capabilities that can harness the urgency, acuity and scalability required to bring life-saving, life-extending products to market. We have experience in a wide range of platforms and technologies including, mammalian, microbial, viral, plasma, and gene therapy to support clinical through commercial manufacturing.